Live Breaking News & Updates on Cantlay harper

Stay informed with the latest breaking news from Cantlay harper on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Cantlay harper and stay connected to the pulse of your community

What's Going On With GSK Stock Today? - GSK (NYSE:GSK)

GSK settles U.S. Zantac lawsuit, avoiding trial. Confidential settlements reinforce commitment to legal efficiency.

California , United-states , Cantlay-harper , David-browne , Reuters ,

GSK settlement keeps it on course to remove Zantac overhang by early 2024, analyst says

GSK PLC's (LSE:GSK, NYSE:GSK) latest out-of-court Zantac deal is important to the ongoing "overhang" over the investment case, Citigroup said. The US...

California , United-states , Cantlay-harper , Citigroup ,

Drugmaker GSK settles California lawsuit on Zantac

Citi and J.P. Morgan estimate GSK's total liability related to the lawsuits to amount to about $5 billion. The trial for the Cantlay/Harper case, which was set to begin on Nov. 13, will now be dismissed, GSK said, adding it had also settled three remaining breast cancer cases in California related to the same drug. The latest settlements in California related to cases due to go to trial in November, with a further set scheduled to begin in Delaware courts in January, GSK said.

United-kingdom , Bengaluru , Karnataka , India , California , United-states , British , Cantlay-harper , Eva-mathews , Nivedita-bhattacharjee , James-goetz , Boehringer-ingelheim

GSK reaches confidential settlement in California Zantac lawsuit

GSK on Wednesday said it had
reached a confidential settlement on a litigation in California
over claims that the British drugmaker's heartburn drug Zantac
caused cancer.
The trial for...

United-kingdom , Bengaluru , Karnataka , India , California , United-states , British , Eva-mathews , Nivedita-bhattacharjee , Cantlay-harper , Reuters , Markets

GSK Settles Zantac Case in California

By Michael Susin

GSK said that it has reached a confidential settlement in the Cantlay/Harper case filed in California state court over claims that its heartburn medicine Zantac can cause...

California , United-states , United-kingdom , British , Cantlay-harper , Michael-susin , Dow-jones , Markets ,

Stocks lower; GSK settles Zantac case in California

Stocks in London are set to open lower on Wednesday as investor looked ahead to the release of the US Federal Reserve's September meeting minutes later in the day.

The minutes are being released...

United-kingdom , London , City-of , Canada , New-york , United-states , Germany , California , North-dakota , German , Ipek-ozkardeskaya , Cantlay-harper

GSK Confirms Settlement In Cantlay/Harper Case

(RTTNews) - Consumer goods and pharma major GSK plc (GSK) on Wednesday confirmed that it has reached a confidential settlement in the Cantlay/Harp...

California , United-states , Cantlay-harper , York-stock-exchange , New-york-stock-exchange , New-york-stock ,

GSK reaches settlement for Zantac litigation in California

GSK PLC on Wednesday said that it has reached a confidential settlement in the Cantlay/Harper case, which alleged that the firm's heartburn medication can cause cancer.

The case, which concerned...

California , United-states , James-goetz , Holly-beveridge , Cantlay-harper , Alliance-news-ltd , Alliance-news , United-kingdom-based , All-rights , Markets ,

FTSE 100 higher; Travis Perkins warns on profit

Stock prices in London opened largely higher on Wednesday as market mood remained resilient, despite the continuing conflict in the Middle East, amid a softening of rhetoric from the US central bank....

California , United-states , Shanghai , China , North-dakota , Dallas , Texas , Sydney , New-south-wales , Australia , Hong-kong , Paris

Drugmaker GSK settles another California lawsuit on heartburn drug Zantac

GlaxoSmithKline (GSK) has announced that it will confidentially settle another lawsuit in California regarding its discontinued heartburn drug Zantac, which is alleged to have caused cancer. The settlement comes as GSK aims to end the costly litigation. The total liability related to the lawsuits is estimated to be around $5 billion.

Delaware , United-states , London , City-of , United-kingdom , California , British , James-goetz , Cantlay-harper , Boehringer-ingelheim , Pfizer , Gsk